š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01946425
In this exploratory study, investigators will be looking at immune response...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT03020537
Treatments Being Tested
Study of the safety and immunogenicity (antibody producing capability) comp...
Status
Completed
Location
Seattle Children's Hospital and Regional Medical Center
Start Date
2005-09
Trial ID
NCT00242424
Treatments Being Tested
The aim of this clinical study is to demonstrate safety and immunogenicity ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691326
To compare the groups with respect to influenza immune responses following ...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00390884
Treatments Being Tested
The study will evaluate the safety and immunogenicity of the 2014-2015 form...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02222870
This phase 3 clinical study is a randomized, observer-blind, multicenter st...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Start Date
2019-05-13
Trial ID
NCT03932682
Treatments Being Tested
To describe the safety findings from Days 0 to 44 following injection of th...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT00836953
Treatments Being Tested
The study is to compare the 2 Groups with respect to antibody responses to ...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00885105
Treatments Being Tested
Primary Objective: To provide the Center for Biologics Evaluation and Rese...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00755274